Insufficient scRNA-seq data for expression of SNX21 at tissue level.
Tissue | GTEx Coverage  | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 100% | 4830.71 | 1809 / 1809 | 99% | 15.92 | 468 / 472 |
| adrenal gland | 100% | 4325.81 | 258 / 258 | 99% | 18.24 | 228 / 230 |
| prostate | 100% | 2700.29 | 244 / 245 | 99% | 13.30 | 499 / 502 |
| kidney | 100% | 1727.37 | 89 / 89 | 99% | 11.50 | 889 / 901 |
| thymus | 100% | 1826.55 | 650 / 653 | 99% | 12.13 | 597 / 605 |
| brain | 98% | 1566.51 | 2594 / 2642 | 100% | 18.48 | 704 / 705 |
| bladder | 100% | 3851.90 | 21 / 21 | 98% | 13.42 | 494 / 504 |
| intestine | 100% | 1985.06 | 966 / 966 | 98% | 9.91 | 515 / 527 |
| lung | 99% | 1796.07 | 575 / 578 | 98% | 15.80 | 1134 / 1155 |
| breast | 100% | 3069.53 | 459 / 459 | 98% | 13.15 | 1091 / 1118 |
| ovary | 100% | 5103.90 | 180 / 180 | 97% | 10.30 | 419 / 430 |
| esophagus | 100% | 2413.58 | 1445 / 1445 | 97% | 8.71 | 178 / 183 |
| stomach | 100% | 1620.30 | 359 / 359 | 97% | 11.10 | 277 / 286 |
| uterus | 100% | 4034.90 | 170 / 170 | 97% | 12.22 | 443 / 459 |
| pancreas | 53% | 365.61 | 174 / 328 | 99% | 12.40 | 176 / 178 |
| liver | 62% | 420.76 | 140 / 226 | 88% | 6.07 | 358 / 406 |
| adipose | 100% | 3457.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3598.35 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 15.39 | 80 / 80 |
| spleen | 100% | 1567.26 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.43 | 1 / 1 |
| muscle | 99% | 2426.35 | 796 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 8.29 | 44 / 45 |
| heart | 97% | 1521.88 | 836 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 48% | 1.95 | 14 / 29 |
| peripheral blood | 22% | 145.38 | 207 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0015031 | Biological process | protein transport |
| GO_0031901 | Cellular component | early endosome membrane |
| GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
| GO_1901981 | Molecular function | phosphatidylinositol phosphate binding |
| GO_0032266 | Molecular function | phosphatidylinositol-3-phosphate binding |
| Gene name | SNX21 |
| Protein name | Sorting nexin-21 (Sorting nexin L) (SNX-L) Sorting nexin family member 21 Sorting nexin family member 21 (cDNA FLJ55851, highly similar to Sorting nexin-21) SNX21 protein (Sorting nexin family member 21) Sorting nexin family member 21 isoform 1 Sorting nexin family member 21 isoform 2 |
| Synonyms | SNXL C20orf161 |
| Description | FUNCTION: Binds to membranes enriched in phosphatidylinositol 3-phosphate (PtdIns(P3)) and phosphatidylinositol 4,5-bisphosphate. May be involved in several stages of intracellular trafficking. . |
| Accessions | Q5JZH4 ENST00000342644.9 [Q969T3-2] ENST00000372542.5 A0A0S2Z5T2 Q05DJ0 ENST00000462307.5 [Q969T3-3] A0A0S2Z632 Q5JZH3 ENST00000372541.1 Q969T3 ENST00000491381.6 [Q969T3-1] ENST00000614929.4 |
